Literature DB >> 33413117

First insights into the molecular basis association between promoter polymorphisms of the IL1B gene and Helicobacter pylori infection in the Sudanese population: computational approach.

Abeer Babiker Idris1, Einas Babiker Idris2, Amany Eltayib Ataelmanan3, Ali Elbagir Ali Mohamed4, Bashir M Osman Arbab5, El-Amin Mohamed Ibrahim6, Mohamed A Hassan7,8,9.   

Abstract

BACKGROUND: Helicobacter pylori (H. pylori) infects nearly half of the world's population with a variation in incidence among different geographic regions. Genetic variants in the promoter regions of the IL1B gene can affect cytokine expression and creates a condition of hypoacidity which favors the survival and colonization of H. pylori. Therefore, the aim of this study was to characterize the polymorphic sites in the 5'- region [-687_ + 297] of IL1B in H. pylori infection using in silico tools.
RESULTS: A total of five nucleotide variations were detected in the 5'-regulatory region [-687_ + 297] of IL1B which led to the addition or alteration of transcription factor binding sites (TFBSs) or composite regulatory elements (CEs). Genotyping of IL1B - 31 C > T revealed a significant association between -31 T and susceptibility to H. pylori infection in the studied population (P = 0.0363). Comparative analysis showed conservation rates of IL1B upstream [-368_ + 10] region above 70% in chimpanzee, rhesus monkey, a domesticated dog, cow and rat.
CONCLUSIONS: In H. pylori-infected patients, three detected SNPs (- 338, - 155 and - 31) located in the IL1B promoter were predicted to alter TFBSs and CE, which might affect the gene expression. These in silico predictions provide insight for further experimental in vitro and in vivo studies of the regulation of IL1B expression and its relationship to H. pylori infection. However, the recognition of regulatory motifs by computer algorithms is fundamental for understanding gene expression patterns.

Entities:  

Keywords:  5′- region; H. pylori; IL1B; In silico analysis; Sudan

Year:  2021        PMID: 33413117      PMCID: PMC7792167          DOI: 10.1186/s12866-020-02072-3

Source DB:  PubMed          Journal:  BMC Microbiol        ISSN: 1471-2180            Impact factor:   3.605


  72 in total

1.  Systematic review with meta-analysis: the worldwide prevalence of Helicobacter pylori infection.

Authors:  M Zamani; F Ebrahimtabar; V Zamani; W H Miller; R Alizadeh-Navaei; J Shokri-Shirvani; M H Derakhshan
Journal:  Aliment Pharmacol Ther       Date:  2018-02-12       Impact factor: 8.171

Review 2.  Gastric cancer: global pattern of the disease and an overview of environmental risk factors.

Authors:  D Forman; V J Burley
Journal:  Best Pract Res Clin Gastroenterol       Date:  2006       Impact factor: 3.043

Review 3.  Epidemiology of Helicobacter pylori infection and gastric cancer in Asia.

Authors:  Kwong Ming Fock; Tiing Leong Ang
Journal:  J Gastroenterol Hepatol       Date:  2010-03       Impact factor: 4.029

Review 4.  Beyond the stomach: an updated view of Helicobacter pylori pathogenesis, diagnosis, and treatment.

Authors:  Traci L Testerman; James Morris
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

Review 5.  Epidemiology of Helicobacter pylori infection and public health implications.

Authors:  Khean-Lee Goh; Wah-Kheong Chan; Seiji Shiota; Yoshio Yamaoka
Journal:  Helicobacter       Date:  2011-09       Impact factor: 5.753

Review 6.  Helicobacter pylori infection: host immune response, implications on gene expression and microRNAs.

Authors:  Aline Cristina Targa Cadamuro; Ana Flávia Teixeira Rossi; Nathália Maciel Maniezzo; Ana Elizabete Silva
Journal:  World J Gastroenterol       Date:  2014-02-14       Impact factor: 5.742

7.  Human and Helicobacter pylori coevolution shapes the risk of gastric disease.

Authors:  Nuri Kodaman; Alvaro Pazos; Barbara G Schneider; M Blanca Piazuelo; Robertino Mera; Rafal S Sobota; Liviu A Sicinschi; Carrie L Shaffer; Judith Romero-Gallo; Thibaut de Sablet; Reed H Harder; Luis E Bravo; Richard M Peek; Keith T Wilson; Timothy L Cover; Scott M Williams; Pelayo Correa
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-13       Impact factor: 11.205

Review 8.  Epidemiology of Helicobacter pylori infection.

Authors:  Olga Sjomina; Jelizaveta Pavlova; Yaron Niv; Marcis Leja
Journal:  Helicobacter       Date:  2018-09       Impact factor: 5.753

Review 9.  Host pathogen interactions in Helicobacter pylori related gastric cancer.

Authors:  Magdalena Chmiela; Zuzanna Karwowska; Weronika Gonciarz; Bujana Allushi; Paweł Stączek
Journal:  World J Gastroenterol       Date:  2017-03-07       Impact factor: 5.742

10.  Age of the association between Helicobacter pylori and man.

Authors:  Yoshan Moodley; Bodo Linz; Robert P Bond; Martin Nieuwoudt; Himla Soodyall; Carina M Schlebusch; Steffi Bernhöft; James Hale; Sebastian Suerbaum; Lawrence Mugisha; Schalk W van der Merwe; Mark Achtman
Journal:  PLoS Pathog       Date:  2012-05-10       Impact factor: 6.823

View more
  3 in total

1.  Comparison of invasive histological and molecular methods in the diagnosis of Helicobacter pylori from gastric biopsies of Sudanese patients: a cross-sectional study.

Authors:  Maram Elnosh; Hisham Altayb; Yousif Hamedelnil; Wafa Elshareef; Aliaa Abugrain; Esraa Osman; Aalaa Albasha; Abdelhamid Abdelhamid; Ehssan Moglad; Ahmed AbdAlla; Ahmed Ismail
Journal:  F1000Res       Date:  2022-01-28

Review 2.  Old and New Aspects of H. pylori-Associated Inflammation and Gastric Cancer.

Authors:  Andreea Ligia Dincă; Lorena Elena Meliț; Cristina Oana Mărginean
Journal:  Children (Basel)       Date:  2022-07-20

3.  Identification of functional tumor necrosis factor-alpha promoter variants associated with Helicobacter pylori infection in the Sudanese population: Computational approach.

Authors:  Abeer Babiker Idris; Alaa B Idris; Manal A Gumaa; Mohammed Babiker Idris; Amanda Elgoraish; Mohamed Mansour; Dalia Allam; Bashir Mo Arbab; Nazar Beirag; El-Amin M Ibrahim; Mohamed A Hassan
Journal:  World J Gastroenterol       Date:  2022-01-14       Impact factor: 5.742

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.